Search results
Colleges backtrack as COVID vaccine mandate lawsuits proceed under SCOTUS mootness doctrine
Just the News· 2 weeks agoIt's not clear the taxpayer-funded institution, which tested the jabs for reduction of symptoms but...
GS1 Connect 2024 Agenda Offers Supply Chain Best Practices Across Retail, Grocery, Foodservice and...
WTNH-TV New Haven· 16 hours agoGS1 Connect 2024, the conference and exhibition hosted by GS1 US, will feature more than 300 leading...
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff - ...
Benzinga· 1 week agoOn Tuesday, Johnson & Johnson JNJ delivered a rather mixed first quarter report. Adjusted earnings...
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
InvestorPlace· 18 hours agoIn the changing environment of 2024, astute investors have a plethora of options to strengthen their...
Andy Johnson
The National Law Review· 2 days agoAndy Johnson is an Attorney at Bradley Arant Boult Cummings LLP. Johnson practices defense of claims against companies that invent, design, manufacture and market co
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoBiotech stocks have been on a roller-coaster ride, but have started to fade in 2024. In 2020, the...
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
FierceBiotech· 2 weeks agoArvinas identified mutant degradation as a way to counter the drug resistance that can arise in...
Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX
Invezz· 3 days agoJohnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent, a CDMO...
U.S. regulators give full approval to Pfizer COVID-19 vaccine
AOL· 5 days agoThe vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which ...
10 Best Performing Biotech ETFs in 2024
Insider Monkey via Yahoo Finance· 3 days agoIn this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just...
